{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:49Z","timestamp":1760060989732,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 DA041489"],"award-info":[{"award-number":["R21 DA041489"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"VA HSR&D","doi-asserted-by":"publisher","award":["CDA 13-279","RCS 00-001","RCS 14-132"],"award-info":[{"award-number":["CDA 13-279","RCS 00-001","RCS 14-132"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jsat.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T11:15:11Z","timestamp":1538478911000},"page":"43-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science"],"prefix":"10.1016","volume":"95","author":[{"given":"Andrea K.","family":"Finlay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid A.","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Timko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Smelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Stimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Bowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex H.S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2018.09.006_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08897077.2015.1062457","article-title":"Counselor training and attitudes toward pharmacotherapies for opioid use disorder","volume":"37","author":"Aletraris","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2018.09.006_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.09.006_bb0015","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","volume":"10","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.jsat.2018.09.006_bb0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11606-008-0881-9","article-title":"Integrating buprenorphine treatment into office-based practice: A qualitative study","volume":"24","author":"Barry","year":"2009","journal-title":"Journal of General Internal Medicine"},{"issue":"7","key":"10.1016\/j.jsat.2018.09.006_bb0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AJP.0000000000000011","article-title":"Trends and regional variation in opioid overdose mortality among veterans health administration patients, fiscal year 2001 to 2009","volume":"30","author":"Bohnert","year":"2014","journal-title":"The Clinical Journal of Pain"},{"issue":"10","key":"10.1016\/j.jsat.2018.09.006_bb0030","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1176\/appi.ps.201200449","article-title":"When quality indicators undermine quality: Bias in a quality indicator of follow-up for alcohol misuse","volume":"64","author":"Bradley","year":"2013","journal-title":"Psychiatric Services"},{"issue":"9","key":"10.1016\/j.jsat.2018.09.006_bb0035","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s11606-007-0264-7","article-title":"Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians","volume":"22","author":"Cunningham","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2018.09.006_bb0040","series-title":"VHA handbook 1160.1","article-title":"Uniform mental health services in VA medical centers and clinics","author":"Department of Veterans Affairs","year":"2008"},{"year":"2015","series-title":"VA\/DoD clinical practice guideline for the management of substance use disorders","author":"Department of Veterans Affairs & Department of Defense","key":"10.1016\/j.jsat.2018.09.006_bb0045"},{"key":"10.1016\/j.jsat.2018.09.006_bb0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2016.01.013","article-title":"Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients","volume":"160","author":"Finlay","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"author":"Fogarty International Center","key":"10.1016\/j.jsat.2018.09.006_bb0055"},{"issue":"1","key":"10.1016\/j.jsat.2018.09.006_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"issue":"6 Pt 2","key":"10.1016\/j.jsat.2018.09.006_bb0065","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/1475-6773.12119","article-title":"Variation in the implementation of California's full service partnerships for persons with serious mental illness","volume":"48","author":"Gilmer","year":"2013","journal-title":"Health Services Research"},{"issue":"2","key":"10.1016\/j.jsat.2018.09.006_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/a0022776","article-title":"Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration","volume":"25","author":"Gordon","year":"2011","journal-title":"Psychology of Addictive Behaviors"},{"issue":"3","key":"10.1016\/j.jsat.2018.09.006_bb0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jsat.2013.09.002","article-title":"A qualitative study of the adoption of buprenorphine for opioid addiction treatment","volume":"46","author":"Green","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2018.09.006_bb0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11606-015-3558-1","article-title":"Are improvements in measured performance driven by better treatment or \u201cdenominator management\u201d?","volume":"31","author":"Harris","year":"2016","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2018.09.006_bb0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1037\/a0030949","article-title":"Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers","volume":"10","author":"Harris","year":"2013","journal-title":"Psychological Services"},{"key":"10.1016\/j.jsat.2018.09.006_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jsat.2015.06.004","article-title":"Possible alternatives to diagnosis-based denominators for addiction treatment quality measures","volume":"58","author":"Harris","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2018.09.006_bb0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ADM.0000000000000203","article-title":"Specifying and pilot testing quality measures for the American Society of Addiction Medicine's standards of care","volume":"10","author":"Harris","year":"2016","journal-title":"Journal of Addiction Medicine"},{"issue":"19","key":"10.1016\/j.jsat.2018.09.006_bb0100","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.2008.648","article-title":"Methadone maintenance 4 decades later: Thousands of lives saved but still controversial","volume":"300","author":"Kleber","year":"2008","journal-title":"JAMA: Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.jsat.2018.09.006_bb0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","article-title":"Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure","volume":"34","author":"Knudsen","year":"2011","journal-title":"Evaluation and Program Planning"},{"issue":"3","key":"10.1016\/j.jsat.2018.09.006_bb0110","first-page":"1","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Systematic Review"},{"issue":"3","key":"10.1016\/j.jsat.2018.09.006_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2018.09.006_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00952990.2012.741167","article-title":"Trends in opioid agonist therapy in the Veterans Health Administration: Is supply keeping up with demand?","volume":"39","author":"Oliva","year":"2013","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2018.09.006_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10488-008-0197-4","article-title":"Implementation research in mental health services: An emerging science with conceptual, methodological, and training challenges","volume":"36","author":"Proctor","year":"2009","journal-title":"Administration and Policy in Mental Health and Mental Health Services Research"},{"issue":"3","key":"10.1016\/j.jsat.2018.09.006_bb0130","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/1475-6773.12524","article-title":"A practical guide to using the positive deviance method in health services research","volume":"52","author":"Rose","year":"2017","journal-title":"Health Services Research"},{"issue":"4","key":"10.1016\/j.jsat.2018.09.006_bb0135","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1475-6773.2011.01377.x","article-title":"Organizational characteristics of high- and low-performing anticoagulation clinics in the Veterans Health Administration","volume":"47","author":"Rose","year":"2012","journal-title":"Health Services Research"},{"key":"10.1016\/j.jsat.2018.09.006_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants \u2014 United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morbidity and Mortality Weekly Report"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721830237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721830237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:48:27Z","timestamp":1760039307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074054721830237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"alternative-id":["S074054721830237X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2018.09.006","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}